Sarah Rogstad


Sarah Rogstad received her Ph.D. in Pharmacology from the University of Colorado and her B.S. in Biology-Chemistry from Harvey Mudd College. She joined FDA as an ORISE postdoctoral fellow in the Office of Testing and Research (OTR) in 2014 and was hired full time in 2015. At FDA, she focuses on mass spectrometry of protein, peptides, and complex products, most recently serving as the lead for the multi-attribute method (MAM) research group. She serves as a mass spectrometry subject matter expert and technical manager for FDA’s Emerging Technology Program/Team (ETP/T).